Clinical Trial Update: An Observational Study of Vonicog Alfa (rVWF) in Pediatric Participants With Von Willebrand Disease (vWD)

View source ↗

Summary

An observational study is underway to evaluate Vonicog Alfa (recombinant von Willebrand factor) in pediatric participants with von Willebrand disease, with recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Von Willebrand Disease

Drugs mentioned

• Vonicog alfa (vonicog alfa)

Snippet

Sponsor: Takeda | Conditions: Von Willebrand Disease (vWD) | Status: RECRUITING